Cliffs Natural Resources Teams Up with Spider Resources

Cliffs Natural Resources Inc. (NYSE: CLF) (Paris: CLF) announced today that it has executed a definitive support agreement with Spider Resources Inc. (“Spider”) (TSXV: SPQ) under which Spider has agreed to support Cliffs’ previously disclosed all-cash offer for Spider at Cdn.$0.19 (“Cliffs’ All-Cash Offer”) per Spider share.

Spider was informed by KWG Resources Inc. ("KWG") (TSXV: KWG) this morning that KWG will not submit an offer to match Cliffs’ All-Cash Offer. As a result, the combination agreement between KWG and Spider (the “Combination Agreement”) has been terminated and Spider has paid KWG a termination fee of Cdn.$2.3 million.

Spider, in accordance with its support agreement with Cliffs, has cancelled the special meeting of Spider shareholders that had been scheduled for July 8, 2019 to consider the proposed merger between KWG and Spider.

“Cliffs’ offer provides immediate value, liquidity and certainty for Spider shareholders,” said William C. Boor, President of Cliffs’ Ferroalloys business unit. “We encourage Spider shareholders to tender their shares by the July 6 deadline to take advantage of our all-cash offer.”

Added Neil Novak, President and CEO of Spider, “We have agreed to give our full support to Cliffs because Cliffs’ All-Cash Offer is clearly in the best interest of Spider’s shareholders. All directors and officers of Spider have agreed to tender their shares under Cliffs’ All-Cash Offer, and we strongly recommend that all other Spider shareholders tender as well.”

Cliffs’ All-Cash Offer for Spider represents a 138% premium over the closing price of the common shares of Spider on the TSX Venture Exchange on May 21, 2010, the last trading day prior to Cliffs’ announcement of its intention to bid for the common shares of Spider. Cliffs’ All-Cash Offer implies a total equity value for Spider on a fully-diluted basis of Cdn.$125 million.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.